Clinical Genomics Technologies
clinicalgenomics.comLocations
Bridgewater, NJ, USA · Sydney, NSW, Australia
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series B
founded in
2006
Clinical Genomics is a privately held biotechnology company developing innovative products for colorectal cancer diagnosis and monitoring. With a broad intellectual property portfolio including more than 20 issued and pending patents, Clinical Genomics has developed and validated a sensitive and specific blood test for colorectal cancer recurrence monitoring that will be launched in the U.S. in 2016. This 2-gene test, which is based on methylated DNA from two genes, BCAT1 and IKZF1, is currently known by its project name GEMINI.
Something looks off?Open jobs at Clinical Genomics Technologies
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.